SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Phytocare informs about revised financial results

04 Nov 2019 Evaluate

Piramal Phytocare has informed that in reference to the letter dated 4th November, 2019 it had enclosed the Unaudited Financial Results for the quarter and half year ended 30th September, 2019 together with the Limited Review Report by the Auditors. In the Statement of Assets and Liabilities as on 30th September, 2019, the figures for the half year ended 30th September, 2019 were inadvertently mentioned as audited instead of unaudited. In this regard, it has enclosed the Revised Unaudited Financial Results for the quarter and half year ended 30th September, 2019; and Limited Review Report by the Auditors.

The above information is a part of company’s filings submitted to BSE.

Piramal Phyt-Amalga Share Price

22.55 0.00 (0.00%)
10-Dec-2019 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×